Literature DB >> 21986854

Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

Savita Jain, Vandana Midha, Ajit Sood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21986854     DOI： 10.1007/s12664-011-0126-4

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  10 in total

1.  [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].

Authors:  Min Ki Shin; Tae Hyo Kim; Kang Ju; Chang Yoon Ha; Hyun Ju Min; Woon Tae Jung; Ok Jae Lee
Journal:  Korean J Hepatol       Date:  2009-09

2.  Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis.

Authors:  G Cadoni; L Marinelli; A De Santis; A Romito; R Manna; F Ottaviani
Journal:  J Laryngol Otol       Date:  1998-10       Impact factor: 1.469

3.  Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy.

Authors:  Victor-K Wong; Cindy Cheong-Lee; Jo-Ann-E Ford; Eric-M Yoshida
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

4.  Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea.

Authors:  M U Akyol; S Sarac; G Akyol; A Atac; A Poyraz; E Belgin; E Turan
Journal:  Otolaryngol Head Neck Surg       Date:  2001-01       Impact factor: 3.497

5.  The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B.

Authors:  Kemal Görür; Ozlem Kandemir; Murat Unal; Cengiz Ozcan
Journal:  Auris Nasus Larynx       Date:  2003-02       Impact factor: 1.863

6.  Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report.

Authors:  Ayşe Tunca; Mustafa Erbayrak; Sirin Aytaç; Cansel Türkay
Journal:  Turk J Gastroenterol       Date:  2004-06       Impact factor: 1.852

7.  Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.

Authors:  Elisabeth Formann; Rudolf Stauber; Doris-Maria Denk; Wolfgang Jessner; Gernot Zollner; Petra Munda-Steindl; Alfred Gangl; Peter Ferenci
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

8.  Interferon-induced sudden hearing loss.

Authors:  Y Kanda; K Shigeno; H Matsuo; M Yano; N Yamada; H Kumagami
Journal:  Audiology       Date:  1995 Mar-Apr

9.  Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.

Authors:  Anna Piekarska; Magdalena Jozefowicz-Korczynska; Kamila Wojcik; Ewa Berkan
Journal:  Int J Audiol       Date:  2007-07       Impact factor: 2.117

10.  A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.

Authors:  Vu Le; Ted Bader; Javid Fazili
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25
  10 in total
  2 in total

Review 1.  A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity.

Authors:  Christine Little; Maura K Cosetti
Journal:  Laryngoscope       Date:  2021-01-27       Impact factor: 2.970

2.  Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line.

Authors:  Allison B Coffin; Emily Dale; Emilee Doppenberg; Forrest Fearington; Tamasen Hayward; Jordan Hill; Olivia Molano
Journal:  Front Cell Neurosci       Date:  2022-08-24       Impact factor: 6.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.